Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
OPHTHALMOLOGICAL COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2023/054669
Kind Code:
A1
Abstract:
The present disclosure pertains to an ophthalmological composition containing: (A) zinc chloride; and (B) a polyvinyl polymer compound.

More Like This:
WO/2021/234094CEFTRIAXONE COMPOSITIONS WITH MAGNESIUM COMPONENT
JP2003507325INDUSTRIAL APPLICABILITY Aerosolized anti-infective agent, anti-inflammatory agent and decongestant for treating sinusitis.
JP7075757ELP fusion protein for controlled and sustained release
Inventors:
MORIKAWA TAKUTO (JP)
MATSUMOTO SACHIKO (JP)
MATSUKI RIE (JP)
Application Number:
PCT/JP2022/036673
Publication Date:
April 06, 2023
Filing Date:
September 30, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ROHTO PHARMA (JP)
International Classes:
A61K47/02; A61K9/08; A61K31/79; A61K33/30; A61K47/32; A61P27/02; A61P27/04; A61P31/04; A61P43/00
Domestic Patent References:
WO2016190306A12016-12-01
WO2013065720A12013-05-10
WO2007106723A22007-09-20
Foreign References:
JP2015531338A2015-11-02
JP2014532641A2014-12-08
JP2019182825A2019-10-24
JP2016179960A2016-10-13
JP2014105157A2014-06-09
JP2011513393A2011-04-28
JP2013525508A2013-06-20
JP2013144671A2013-07-25
JP2013144672A2013-07-25
JP2021075531A2021-05-20
JPH07196474A1995-08-01
JP2007530685A2007-11-01
JP2010504358A2010-02-12
Other References:
"Approval Criteria for Marketing Guidance-Required Over-the-Counter Pharmaceuticals", 2017
Attorney, Agent or Firm:
HASEGAWA Yoshiki et al. (JP)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: Amorphous Tolvaptan-Containing Composition

Next Patent: MEDICAL DRESSING MATERIAL